Moreover, AhR regulates the expression of IDO1 and TDO. Regarding the tumor microenvironment, a decreased level of tryptophan caused by IDO1 and TDO activity may result in loss of immune function through the suppression of antigen-specific T-cell response and stimulation of DC-mediated immune tolerance [124]. This evidence concerns the gene IDO1 and neoplasm.